$138.97
0[0.00%]
At close: Apr 24
$138.97
0[0.00%]
PreMarket: 4:20PM EDT
Neurocrine Biosciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Neurocrine Biosciences using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/01/2024 | AM | NBIX | Q1 | -$0.51 | $1.00 | — | — | $420.40M | $514.49M | — | — | Get Alert |
02/07/2024 | AM | NBIX | Q4 | $1.24 | $1.15 | $1.54 | 33.91% | $412.00M | $518.13M | $515.20M | -0.57% | Get Alert |
10/31/2023 | AM | NBIX | Q3 | $1.08 | $0.98 | $1.54 | 57.14% | $387.90M | $469.92M | $498.80M | 6.15% | Get Alert |
08/01/2023 | AM | NBIX | Q2 | $0.84 | $0.77 | $1.25 | 62.34% | $378.20M | $448.89M | $452.70M | 0.85% | Get Alert |
05/03/2023 | AM | NBIX | Q1 | $0.30 | $0.13 | -$0.51 | -492.31% | $310.60M | $409.35M | $420.40M | 2.70% | Get Alert |
02/06/2023 | AM | NBIX | Q4 | $0.04 | $1.14 | $1.24 | 8.77% | $312.00M | $409.09M | $412.00M | 0.71% | Get Alert |
11/01/2022 | AM | NBIX | Q3 | $0.64 | $0.80 | $1.08 | 35.00% | $296.00M | $376.50M | $387.90M | 3.03% | Get Alert |
08/04/2022 | PM | NBIX | Q2 | $0.63 | $0.59 | $0.84 | 42.37% | $288.90M | $341.31M | $378.20M | 10.81% | Get Alert |
05/04/2022 | AM | NBIX | Q1 | $0.49 | $0.34 | $0.30 | -11.76% | $236.60M | $303.40M | $310.60M | 2.37% | Get Alert |
02/11/2022 | AM | NBIX | Q4 | $0.91 | $0.52 | $0.04 | -92.31% | $247.90M | $316.79M | $312.00M | -1.51% | Get Alert |
11/01/2021 | PM | NBIX | Q3 | $0.97 | $0.60 | $0.64 | 6.67% | $258.50M | $297.65M | $296.00M | -0.55% | Get Alert |
08/03/2021 | PM | NBIX | Q2 | $1.42 | $0.49 | $0.63 | 28.57% | $302.40M | $274.38M | $288.90M | 5.29% | Get Alert |
05/05/2021 | PM | NBIX | Q1 | $0.82 | $0.51 | $0.49 | -3.92% | $237.10M | $250.63M | $236.60M | -5.60% | Get Alert |
02/04/2021 | PM | NBIX | Q4 | $1.05 | $0.54 | $0.91 | 68.52% | $244.10M | $262.40M | $247.90M | -5.53% | Get Alert |
11/09/2020 | PM | NBIX | Q3 | $0.90 | $0.22 | $0.97 | 340.91% | $222.09M | $283.04M | $258.50M | -8.67% | Get Alert |
08/03/2020 | PM | NBIX | Q2 | $0.71 | $0.73 | $1.42 | 94.52% | $183.58M | $260.34M | $302.40M | 16.16% | Get Alert |
05/06/2020 | PM | NBIX | Q1 | -$1.12 | $0.54 | $0.82 | 51.85% | $138.40M | $223.87M | $237.10M | 5.91% | Get Alert |
02/04/2020 | PM | NBIX | Q4 | $0.19 | $0.75 | $1.05 | 40.00% | $131.49M | $230.94M | $244.10M | 5.70% | Get Alert |
11/04/2019 | PM | NBIX | Q3 | $0.52 | $0.64 | $0.56 | -12.50% | $151.76M | $211.63M | $222.09M | 4.94% | Get Alert |
Neurocrine Biosciences (NBIX) is scheduled to report earnings on May 1, 2024. The last reported earnings were for reported on February 7, 2024 for Q4.
The Actual EPS was $1.54, which beat the estimate of $1.15.
The Actual Revenue was $515.2M, which missed the estimate of $518.1M.
Browse earnings estimates, EPS, and revenue on all stocks.